Meeting consumers’ expectations: How digital health technology can help transform care

Meeting consumers’ expectations: How digital health technology can help transform care
Clinicians and people have differing viewpoints on and expectations of telehealth and other types of digital treatment. Digital health know-how product leaders perform a crucial role in aligning these viewpoints and expectations so that they can aid supply what healthcare people want without the need of introducing to clinicians’ burdens.

Ever more, individuals have large anticipations of their health care encounters, which include these that come about virtually.
Virtual technological know-how can assist address issues in obtain and ease of care through, for illustration:

  • Telemedicine
  • Healthcare clinics in retail suppliers and pharmacies
  • Digital health and fitness apps
  • Remote monitoring products and wearables
  • Or subscription-based memberships

Consumers want treatment delivered the place, when, and how the desire it. In addition, they want superior interaction, digital engagement, and conversation with companies.

Which is improved from in advance of the pre-pandemic baseline. Then, individuals and sufferers ended up primarily contemplating – and employing – virtual care for prescriptions refill. In accordance to a survey of 7,000 individuals by the Advisory Board, willingness has completely shifted currently. For example, extra than 60{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} of individuals would now take into consideration going digital for ongoing treatment, pre-surgical appointments, and publish-surgical comply with-ups, or acquiring oncology benefits. And there’s much more.

Medical professionals are not so confident about digital treatment

Providers, nevertheless, never always see it the same way. A McKinsey survey uncovered that 62{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} of doctors mentioned they recommend in-human being in excess of virtual treatment to sufferers. Many are also not certain that telehealth can boost the affected person encounter. This disconnect can be highly-priced, as sufferers can swap providers and alter modalities of care extra conveniently.

When some physicians are nevertheless on the fence, businesses are all in. In the 2022 KFF Study of Employer Well being Added benefits, 90{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} of employers said telemedicine will be vital in offering obtain to care for behavioral, primary, and specialty care, and in remote options.

How can electronic overall health technological innovation help remodel care?

Digital health engineering companies and product leaders can engage in an crucial role in improving the healthcare knowledge and the wellness of people. For case in point, they can help decrease the disconnect amongst clients and providers.

A great digital care solution can also improve the romance amongst the patient and the supplier by aiding clinicians hone their “web-side” manner, the digital substitute to bedside manner. A further way is to emphasis on smart affected individual schooling with the proper content material and applications as an powerful alternate to help control queries questioned to clinicians.

Expectations and thoughts about virtual care and telehealth will most likely proceed to change. But for organizations and innovators in digital overall health technologies, the time to act on the prospect is now.

Uncover the vital position electronic overall health technologies corporations and leaders can participate in in aligning the expectations of clinicians, sufferers, and health and fitness plans, and how they can travel health care forward in our new whitepaper, Aligning Digital Treatment Delivery to Consumers’ Expectations.

PULSEPOINT LAUNCHES ALL-CHANNEL MEASUREMENT FOR INSIGHT-DRIVEN CONSUMER ACTIVATION IN PARTNERSHIP WITH KOMODO HEALTH

PULSEPOINT LAUNCHES ALL-CHANNEL MEASUREMENT FOR INSIGHT-DRIVEN CONSUMER ACTIVATION IN PARTNERSHIP WITH KOMODO HEALTH

Built-in Measurement Provides Actionable, Privateness-Secure Patient Insights for Serious-Time Organizing, Activation, and Optimization

NEW YORK, Feb. 27, 2023 /PRNewswire/ — PulsePoint, a technological innovation corporation revolutionizing wellbeing choice-making in genuine time, right now declared the launch of integrated direct-to-shopper (DTC) measurement methods in partnership with Komodo Wellbeing, a major health care technology organization that has designed the industry’s most full and linked watch of affected individual encounters. PulsePoint consumers utilizing the Lifestyle system can now leverage Komodo Health’s superior analytic capabilities and insights visualization resources for initially-bash viewers profiling and measurement, in addition to PulsePoint’s initially-occasion and proprietary collection of intelligence tools.

Knowledge what influences individuals to just take medical action with a manufacturer has become increasingly difficult. Models need to have true-time visibility into their steps to fully have an understanding of how to influence what they might do next along the affected person journey. People that are not measuring properly are most probable performing on insights that you should not validate if messaging essentially arrived at a patient in the 1st location. An impartial solution to measurement is essential to making sure marketers have a complete and accurate being familiar with of what’s working so they’re in the greatest situation to boost campaigns that are underperforming.

Combining PulsePoint information with the Komodo Health care Map and configurable measurement answers supplies impartial, 3rd-celebration DTC marketing campaign measurement on uncovered and unexposed audiences. This enables PulsePoint customers to harness actionable, privacy-secure audiences with Komodo’s scientific and digital intelligence to rapidly respond to evolving patient behaviors driven by true-time campaign outcomes planned, activated, and optimized on Lifetime. Serious-time measurement will allow for real-time optimizations to better access clients inside the targeted wellbeing ailment and generate improved results.

 Key omnichannel measurement capabilities incorporate:

  • Realize what methods to prioritize to enhance viewers good quality and improve certified viewers effect.
  • Drill down into important demographic and scientific insights about the audience arrived at, this kind of as geo-locale, age, and gender, being aware of who initiated, refilled, or stopped an Rx, or switched to or from a competitor.
  • Identify campaign-driven script elevate for exposed and unexposed patients primarily based on a check and control methodology operate dynamically, in actual time.

“PulsePoint has a sizeable competitive gain as it relates to fidelity, flexibility, and accessibility, which permits us to provide a much better, 1st-party stage of perspective of the client with actionable outcomes to optimize campaigns and strategy that other DTC measurement remedies cannot,” stated Andrew Stark, Chief Income Officer at PulsePoint. “Our one of a kind solution to shut-loop measurement and wide range of remedies allow for PulsePoint to deliver the greatest attainable HCP and DTC viewers achieve result in in the vicinity of real time.” 

“This partnership fuels a unique opportunity for PulsePoint purchasers to gain a additional comprehensive and representative perspective of their affected individual audience, and hook up the dots in between personal affected individual journeys and large-scale medical results,” reported Aswin Chandrakantan, MD, Main Operating Officer at Komodo Wellbeing. “As life sciences groups goal to choose a far more data-pushed tactic to DTC general performance measurement, these new options can support give a window into serious-time campaign changes that can be designed to fortify engagement.”

This announcement furthers PulsePoint’s focus on setting up a smarter, much more scalable, far more efficient way for manufacturers to target, achieve, comprehend, and activate health care audiences via upcoming-era know-how that is run by confirmed well being audience knowledge in actual time. 

About PulsePoint

PulsePoint is a foremost technological innovation firm that utilizes authentic-globe knowledge in real time to improve campaign performance and revolutionize well being selection-generating. Leveraging proprietary datasets and methodology, PulsePoint targets health care experts and individuals with an unprecedented stage of accuracy—delivering unparalleled effects to the purchasers we provide. The organization is now a portion of Internet Manufacturers, a KKR portfolio company and proprietor of WebMD Well being Corp. For far more info, take a look at pulsepoint.com.

Speak to:
Sanwari Gupta
sagupta@pulsepoint.com

Resource PulsePoint

Healthcare metaverse: Merging technology with medicine

Healthcare metaverse: Merging technology with medicine

Technological innovation is substantially advancing the way we diagnose and treat clients. In current moments, telehealth and in-residence healthcare increasingly turned integrated into our everyday life, which further more gave start to the metaverse in health care.

Metaverse is correctly the up coming version of the online — one that will take benefit of synthetic intelligence (AI), augmented reality (AR), digital reality (VR), and connectivity to develop on the internet environments that are more immersive, experiential and interactive than what we have currently.

In the health care sector, the metaverse is also swiftly gaining traction. AI, AR, the Online of Things (IoT), virtual fact, quantum computing, and robotics are all expected to improve healthcare supply and greatly enhance client results. The metaverse involves the convergence of main know-how traits that have the probable to effects healthcare individually.

Together, they could make entirely new channels for providing care that have the possible to reduce charges and vastly improve client results. These three traits are telepresence (making it possible for people to be collectively just about, even whilst we’re apart physically), digital twinning, and blockchain.

It may sound like science fiction today, but it is the future stage in the way we provide healthcare, say authorities. It was not too lengthy ago that owning a doctor stop by your household was not uncommon. That is likely to come about again, except this time engineering is currently being made use of as an enabler.

Healthcare leaders need to have to comprehend how these improvements can address the soreness points for each prospects and staff members due to the fact the metaverse is predicted to develop exponentially in the coming a long time. In accordance to a report titled ‘Healthcare in the Metaverse’ from Sector Analysis Potential, the health care metaverse sector is predicted to increase at a CAGR of 48.3 for every cent until eventually 2030, with the industry’s value anticipated to leading US$5.37 billion.

In the latest yrs, augmented truth and virtual fact systems have innovative enormously, and they are now commonly utilized in health-related coaching, educating modules, and surgical procedures to perform complex surgeries with excessive precision. These factors are also utilized in healthcare devices and products application and hardware to boost their effectiveness.

In an previously interview with Omnia Health Insights in 2022, Aravind Upadhyaya, Founder and CEO of 8chilli said that health and fitness systems and academic institutions that do not embrace this advanced technological know-how for superior affected individual treatment and schooling wants will lose the struggle in the following 8 a long time.

He also stated: “I see an acceleration in the adoption of electronic wellbeing technologies, specifically wearables followed by AR/VR and therapeutics. In the long-expression, Net 3., or the metaverse as we now call it, will enjoy a vital function in the health care ecosystem as countries invest far more time in the metaverse. Healthcare is relocating in the direction of value-centered treatment and VR provides the top-quality results expected to reach worth-based treatment.”

This year’s Arab Overall health, with its freshly introduced Clever Health and fitness Pavilion, outlined the most modern and sustainable healthcare systems by way of reside demonstrations at the Foreseeable future Wellbeing Summit held in the Museum of the Foreseeable future.

“The health care sector has witnessed amazing changes in current many years, with know-how and innovation the driving drive driving how the market is elevating client care,” claimed Ross Williams, Exhibition Director for Informa Markets.

The Clever Health Pavilion will attribute a few demonstration rooms showcasing numerous new technologies via stay demonstrations which include a digital Intense Treatment Device (ICU), an clever operating place, and an unexpected emergency room.

“The summit is devoted to trailblazers. From AI and robotics to the part of the metaverse, the health care industry is continually evolving because of chopping-edge know-how combined with revolutionary leaders committed to enhancing client results,” Williams said.

He added: “The metaverse is envisioned to disrupt health care and open up new channels of therapy although decreasing charges. The predicted growth inside this market place is enormous, and we have only explored the idea of the iceberg.”

The Long run Overall health Summit provided an a must have seem at how everyone in the health care sector can maximise what it delivers.

Before this year, UAE healthcare organization Thumbay Group introduced its have intentions to create a virtual healthcare facility where by medical professionals and sufferers can satisfy as avatars for distant consultations. Thumbay Group and the Gulf Healthcare University are also doing work with each other to integrate Virtual Truth (VR) into health care training.

Even though metaverse skeptics could possibly argue that this kind of initiatives are small much more than telehealth with 3D eyeglasses, one more project unveiled at the GITEX 2022 convention in the Dubai Environment Trade Centre is proving that distant medical treatment can go further than consultations to therapy.

This write-up seems in the most recent concern of Omnia Health and fitness Journal. Read through the total concern on-line right now.

< Back to Technology

 

Evidence from ClinicalTrials.gov on the growth of Digital Health Technologies in neurology trials

Evidence from ClinicalTrials.gov on the growth of Digital Health Technologies in neurology trials

The burden of neurological disorders is growing in the US and abroad, with neurological conditions representing the most frequent cause of disability worldwide1. The resulting consequences are considerable individual suffering and substantial societal healthcare costs2,3. R&D investments are needed to identify new therapies, but clinical research faces challenges including high costs, administrative hurdles, and challenging patient recruitment4,5,6. Furthermore, clinical trials and their associated follow-up visits burden patients and their relatives7, especially for those with highly disabling neurological diseases.

Against this backdrop, the use of digital tools, such as connected sensors, promises to make research more patient-centered and move clinical trials beyond single “snapshots” of disease status toward more continuous measurement of chronic disorders8. Connected digital products9 or Digital Health Technologies (DHTs)10,11 are software-containing, patient-focused, portable, and connected sensors of health-related measurements, which describe different products, including many wearables. DHT examples from current FDA guidance include spirometers with smart connectivity, consumer activity trackers, and mobile applications for patients to report outcomes11. Such connected sensors may improve both the quantity and quality of data collection during clinical trials and enable patient recruitment in a less burdensome and more patient-empowering remote setting9.

In neurological diseases such as Parkinson’s disease (PD), use of validated, reliable, and sensitive tools has already been shown to provide better data on the “real-life distribution of disease severity, as it fluctuates longitudinally” in early-stage patients12,13. DHTs can therefore facilitate new study designs12, improve the efficiency of clinical trials14,15,16, and contribute to tackling many of the challenges neurological research faces. As more researchers adopt such technologies, understanding the use and development of DHTs in neurological clinical trials will be valuable for investigators, practicing clinicians, and those designing patient care pathways. As such, this study documents trends in the use of DHTs in neurology research and highlights opportunities for both R&D activities and care delivery going forward.

We assessed studies registered on ClinicalTrials.gov for four exemplary chronic neurological disorders. Building on methods from Marra et al. (2020)9, we identified trial-indication pairs for clinical studies in epilepsy, the neuroinflammatory disease multiple sclerosis (MS), and the two neurodegenerative diseases, PD and Alzheimer’s disease (AD). We present quantitative and qualitative (categorical) analyses of the trials that used connected sensors to describe technology adoption in neurology research and outline underlying trends over the years 2010-2021, inclusive.

Of the 6763 trial-indication pairs for epilepsy, MS, AD, and PD considered, 503 trial-indication pairs were identified as using DHTs by our search algorithm. After manual verification, 441 trial-indication pairs, associated with 430 unique clinical trials, were determined to be relevant and included in the analysis sample (Supplementary Fig. 1). Analysis sample trial counts varied significantly across indications: most frequent were studies in PD (198, 44.9{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}), followed by MS (119, 27.0{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}), AD (87, 19.7{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}), and epilepsy (37, 8.4{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}).

We document growth in the use of DHTs in neurological clinical trials, with a compound annual growth rate of ~39{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} from 2010 – 2020, consistent with trends in DHT growth that have been documented in registered clinical studies more broadly9. Most analyzed trials were interventional, with DHT trials based on registries having started only in recent years and typically incorporating some kind of digital activity or speech tracking (Fig. 1).

Fig. 1: Development of clinical trials for chronic neurological diseases by year of initiation, trial type and indication.
figure 1

a Number of analyzed studies using Digital Health Technologies (DHTs) per year, stratified by the type of the respective trial. Line depicts the percentage of DHT trials out of all trials for the analyzed indications starting in the respective year. b Number of analyzed studies using DHTs per year, stratified by the indications epilepsy (Epi.), Alzheimer’s disease (AD), multiple sclerosis (MS), and Parkinson’s disease (PD). * Data for the year 2021 may be incomplete due to late registrations on ClinicalTrials.gov.

The relative frequency of DHT use in trials for the focal conditions increased from 0.7{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} of trials in 2010 to 11.4{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} in 2020. PD trials showed early uptake of DHTs and the highest use rate over the full period of the study (8.3{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} on average). AD, MS, and epilepsy trials showed a delayed upward trend, with respective use rates of 7.3{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}, 5.8{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}, and 3.3{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} overall (Supplementary Table 1).

Among all DHT trials, 16.6{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} included an industry sponsor or collaborator – slightly less frequently than the 19{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} previously documented across all medical disciplines9 – with industry partnerships more commonly observed in trials for epilepsy (37.8{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}) and AD (23.0{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}) (see Supplementary Fig. 2).

With respect to studies’ categorical (qualitative) features, most trials tracked patient symptoms (91.4{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}), with exceptions focusing on vital signs of caregivers or other disease-related outcomes such as medication adherence. The majority of trials measured motor functions (68.9{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}), with many including exercise elements (34.7{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}), sometimes through the use of gaming consoles (7.9{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}). Sleep (15.4{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}), cognition (10.4{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}), and speech (4.3{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}) tracking were less common as were gamification (19.3{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}), caregiver support (6.6{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}), and medication adherence (4.3{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}) elements (Table 1). A large share of studies used some form of mobile application (35.1{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}) and the most commonly referenced DHTs were wearables (129, 29.3{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}), smartphones (76, 17.2{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}), actigraphs (48, 10.9{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}) and mobile applications (42, 9.5{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}) (see Supplementary Table 2).

Table 1 Qualitative (categorical) features of trials by indication.

PD and MS trials often focused on motor symptoms and physical exercise, with a high share of gamification elements in MS trials. Other observed characteristics included numerous caregiver support and speech recognition tools in AD trials, frequent sleep tracking in AD and epilepsy trials, cognition tracking in AD and MS trials, and a recurrent tracking of medication adherence in epilepsy trials (Table 1).

Generally, a trend toward more complex and more extensive studies was observed, as represented by a gradual change in categorical trial features over time (Fig. 2). Whereas the use of motor function and exercise tracking were already observed in 2010, speech and cognition tracking were not observed until the mid-2010s (Fig. 2). Speech and cognition tracking both grew over time and were present in 8.1{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} and 14.0{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} of analyzed DHTs using trials in 2021, respectively (Supplementary Table 1). Conversely, the relative use of gamification elements decreased slightly in more recent years (Supplementary Table 1).

Fig. 2: Use of selected Digital Health Technology tracking modalities in trials registered on ClinicalTrials.gov for chronic neurological diseases by year of trial initiation.
figure 2

Number of ClinicalTrials.gov registered trials of four different neurological indications using DHTs for different tracking modalities by trial initiation year (green bar plots). Additionally, rate of these studies compared to all trials for the same indications registered on ClinicalTrials.gov for the respective year is shown (orange line). Trials for the indications epilepsy, Alzheimer’s disease, multiple sclerosis, and Parkinson’s disease were included. a Absolute number and share of all trials for motor function tracking. b Absolute number and share of all trials for sleep tracking. c Absolute number and share of all trials for cognition tracking. d Absolute number and share of all trials for speech tracking. * Data for the year 2021 may be incomplete due to late registrations on clinicaltrials.gov.

Most registered trial-indication pairs were identified in North America or Europe, with a large share of trials having principal investigators in the US (209, 47.4{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}), followed by Italy and France (both 28 or 6.3{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} each), the UK (19, 4.3{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}), Belgium (17, 3.9{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}), Switzerland (16, 3.6{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}), Israel (14, 3.2{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}), Canada, Turkey, and Germany (all 13 or 2.9{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} each). In total, trials from 33 countries and all inhabited continents were included in the analysis sample. Some regions showed a local/regional concentration of DHT studies, often related to a specific indication. An interactive map displaying the locations of sample trials are publicly accessible at https://www.reine-nervensache.de/eigene-forschungsergebnisse/digital-health-technologies-in-neurology-trials.

Qualitatively, included studies displayed heterogeneity in their aims. Whereas some clinical trials aimed to validate products or novel biomarkers, others already applied them as endpoints in studies of other interventions.

While some have highlighted insufficient prospective clinical research applying DHTs and mobile health17, the use of DHTs in neurology trials has not previously been characterized in detail. We analyzed disease-specific DHT adoption in trials registered on ClinicalTrials.gov to provide insights specific to four chronic neurologic diseases.

The analysis confirmed a clear trend in DHT adoption, with some disease-specific heterogeneity. The earlier application of such tools in disorders with primarily motoric symptoms, such as PD or MS, is likely due to the early availability of wearable sensors to track motor functions and might contribute to the higher number of trials observed for these two indications. However, as novel sensors and sophisticated technical setups became available in more recent years, multimodal clinical trials tackling diverse research questions with DHTs began to emerge. This development is evident in the subset of AD trials, where recent growth in the share of trials using DHTs is consistent with increasing readiness of novel digital measures that integrate speech and cognition tracking18,19. In parallel, the repertoire of DHTs used in early-adopting subfields has also expanded, for example through potential PD monitoring technologies that now include passive tremor monitoring via wearables12,13, smartphone-based motor and vocal symptom assessments20,21, gait analysis via smart insoles22, and sensors for swallowing23.

Interestingly, pharmaceutical companies tested self-developed DHTs in some trials24,25,26, indicating a possibility for broader prospective adoption by other stakeholders. Differences in the share of industry-sponsored trials across neurologic diseases could indicate differences in experience with digital measures across indications or difference in research funding for different diseases (either within firms themselves and/or from investments by research foundations or public funders). Any of these factors could shape biopharmaceutical and medical device firms’ investments in their use in clinical trials. Regions with a higher density of clinical trials using DHTs differ in their indication-specificity, suggesting different backgrounds and foci of research teams: high-density areas with multiple indications were more frequent in the US and could indicate technology-driven research, whereas regional clusters focusing on research in a single indication appeared more common in other countries.

Some digital measures assessed in the analysis sample integrate information previously unavailable to clinicians and researchers, such as details of smartphone usage27 or characteristics of patient-caregiver-interactions28,29, in one case deploying real-time monitoring of mood and stress via a smart-home approach29. Monitoring cognitive and motor skills with ‘byproduct data’ such as metadata on smartphone keystroke dynamics, for example, in epilepsy27 or MS30, could allow remote monitoring to be passively and therefore more seamlessly integrated into patients’ daily lives and eventually, into clinical routines. Further examples of the use of previously inaccessible data for novel phenotyping include approaches such as longitudinal repetitive cognitive testing18,31, speech characterization32, or swallowing monitoring23. Especially in more complex recent studies, digital biomarkers or measures were observed in conjunction with biological and radiological biomarkers22,33, promising a more detailed overview of patients’ health status than ever before. Furthermore, the small but growing trend of monitoring and supporting caregivers or relatives via DHTs28,29 could preview new forms of promising assistance for these essential but often neglected alleviators of the burdens of chronic diseases. A personalized prevention of secondary burn-out or depression among caregivers could be supported by DHTs that objectively track interactions with patients and monitor caregivers’ vital signs and stress28,29.

The observed heterogenous use pattern of DHTs in the analysis sample highlights different use cases for validating DHTs, gathering data with DHTs, or using DHTs as interventions; understanding this heterogeneity should be a focus of future research. Examples of trials categorized by the use cases according to Marra et al.9 can be found in Supplementary Table 3. Generally, there appears to be a large variety of new therapeutic and monitoring solutions under study, although solutions often remain fragmented, stand-alone approaches, making it difficult to bring user-friendly, holistic approaches into practice at scale.

The growing share of disease-specific trials applying DHTs show that neurological research is already adapting and increasingly integrating remote digital measurements into its research agenda. In addition to growing adoption of established digital measures, such as motor function, novel approaches, such as speech and cognition tracking are being deployed more often.

Recent regulatory trends further support this development, as seen in the first qualification of a digital endpoint by the EMA in Duchenne muscular dystrophy34, a neuromuscular disorder, and published guidance for applying DHTs by the FDA11. Nevertheless, there remains ample opportunity to extend the use of DHTs in clinical trials and support their transition into routine clinical care. Different technologies promise improved patient healthcare access and new setups for decentralized clinical trials, thereby enabling previously unimaginable measures for gathering real-world evidence. Further research is needed to clarify what is required for broader adoption in practice, thus enabling the translation of verified, analytically validated, and clinically validated tools35 into improved patient care.

Methods

We identified DHTs in trials registered on ClinicalTrials.gov following Marra et al. (2020)9 and using an updated and curated version of the searched product list (see Supplementary Note 1 and GitHub repository in the Data Availability Statement). Additionally, trials were filtered for the conditions epilepsy, MS, AD, or PD, resulting in a dataset built around unique trial-indication pairs (only 10 trials had multiple indications). The analysis sample was restricted to trials launched from 2010–2021 (inclusive) that had at least begun recruitment. Data were retrieved on February 28th, 2022. The resulting set of records was analyzed for the use of DHTs and trials that referenced such products were included in the analysis and mapped to a list of relevant categories defined for this purpose. This list included non-mutually-exclusive features such as different tracking characteristics as listed in Table 1 and Supplementary Table 1 (mapping was carried out by L.M. and P.G.). For comparison, other contemporaneous trials for the same indications were pulled from ClinicalTrials.gov. All analyses were run using Python 3.8 (Python Software Foundation, Delaware, USA). An interactive map of the principal trial locations was generated using plotly version 5.4.036 after geocoding addresses with geopy version 2.2.037. The co-author team included a patient with one of the focal disorders.

Reporting summary

Further information on research design is available in the Nature Research Reporting Summary linked to this article.

One Medical joins Amazon to make it easier for people to get and stay healthier

One Medical joins Amazon to make it easier for people to get and stay healthier

For a limited time, One Medical membership is available to new U.S. customers for $144 (28{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} discount) for the first year—the equivalent of only $12 per month.

Amazon and One Medical announced that Amazon completed its acquisition of One Medical. One Medical’s seamless in-office and 24/7 virtual care services, on-site labs, and programs for preventive care, chronic care management, common illnesses, and mental health concerns have been delighting people for the past 15 years. Together, Amazon and One Medical look to deliver exceptional health care to more people to achieve better health outcomes, better care experiences, and more value, within a better care team environment. For a limited time, One Medical is offering annual memberships at the discounted price of $144 for the first year (regularly $199 per year), the equivalent of $12 per month, to new customers. Redeem the One Medical membership promotion and learn more about what’s included.

“We’re on a mission to make it dramatically easier for people to find, choose, afford, and engage with the services, products, and professionals they need to get and stay healthy, and coming together with One Medical is a big step on that journey,” said Neil Lindsay, senior vice president of Amazon Health Services. “One Medical has set the bar for what a quality, convenient, and affordable primary care experience should be like. We’re inspired by their human-centered, technology-forward approach and excited to help them continue to grow and serve more patients.”

“One Medical has been on a mission to help transform health care through its human-centered and technology-powered model to delight people with better health, better care, and better value, within a better team environment,” said Amir Dan Rubin, CEO of One Medical. “We now set our sights on delivering even further positive impacts for consumers, employers, care teams, and health networks, as we join Amazon with its long-term orientation, history of invention, and passion for reimagining a better future.”

“If you fast forward 10 years from now, people are not going to believe how primary care was administered. For decades, you called your doctor, made an appointment three or four weeks out, drove 15-20 minutes to the doctor, parked your car, signed in and waited several minutes in reception, eventually were placed in an exam room, where you waited another 10-15 minutes before the doctor came in, saw you for five to ten minutes and prescribed medicine, and then you drove 20 minutes to the pharmacy to pick it up—and that’s if you didn’t have to then go see a specialist for additional evaluation, where the process repeated and could take even longer for an appointment,” said Amazon CEO Andy Jassy. “Customers want and deserve better, and that’s what One Medical has been working and innovating on for more than a decade. Together, we believe we can make the health care experience easier, faster, more personal, and more convenient for everyone.”

One Medical sets a high bar for human-centered primary care experiences:

Access to primary care where, when, and how people prefer, with:

  • Around-the-clock access through the One Medical app, giving people more control of how they seek care and the ability to do so from home or on-the-go
  • On-demand virtual care services, like 24/7 video chats and easy in-app messaging, which are included in membership at no extra cost; for other services, such as in-office appointments, One Medical accepts most major insurance health plans
  • Same and next-day in-office or remote visits, so people can quickly get the care they need
  • Thoughtfully designed and welcoming One Medical offices, offering care close to where people work, live, and shop
  • Walk-in availability for on-site laboratory services, making it easy to get lab work done where and when it’s most convenient

A comprehensive approach to make health care easier to navigate by offering:

  • A health care home base with primary care providers that help manage a person’s full health picture; from preventive and acute care needs, to chronic disease and mental health concerns
  • Pediatricians and family care providers available in a growing number of locations, serving children and families
  • Providers trained to address both physical and mental health needs, which may include lifestyle recommendations, medications, or referrals to appropriate specialists
  • Clinical and digital integrations with leading hospital networks across the U.S. for more seamless access and coordinated care across primary and specialty care services
  • Easy access to vaccine and medical records, prescription renewals, specialty referrals, and lab results in the One Medical app
  • Outstanding care for seniors in a growing number of locations, with teams specialized in serving people on Medicare

A more human health care experience enabled by:

  • Highly engaged clinicians focused on meeting the whole needs of people, thinking about health care comprehensively, and taking time to treat people as people and not solely as diagnoses
  • More time in appointments to engage with providers for more personalized and comprehensive health care
  • Proactive app reminders for follow-up care and referral needs, facilitating better prevention and coordination of care so the dots are better connected for people to get and stay healthier
  • A human-centered and technology-powered approach, offering an easy-to-use app and innovative clinician tools to simplify the experience for both the patient and the provider

FAQ

For customers looking for additional information, here are answers to some frequently asked questions:

  • What does the One Medical membership fee cover?

    The One Medical annual membership fee covers access to One Medical’s on-demand and asynchronous virtual care services as well as high-touch and value-added personal services such as insurance navigation and referral management. The on-demand virtual services are accessible through the One Medical app (at no additional cost), featuring 24/7/365 on-demand video chats, secure provider messaging, “Treat Me Now” assessments for common health concerns, easy vaccine and medical record access, prescription renewals, and proactive reminders for follow-up care and referral needs.

  • What does One Medical joining the Amazon family mean for current One Medical members?

    One Medical members can continue to count on One Medical for the high-quality care and high-level of service they receive. One Medical looks forward to continuing to increase access to care and improve health outcomes with the support of Amazon.

  • How does One Medical differ from a typical primary care or urgent care practice?

    One Medical aims to make health care easier to access and even enjoyable, while improving health outcomes for people across every stage of life. One Medical offers same and next-day in-office or remote visits, seamlessly paired with 24/7 on-demand virtual care services through the One Medical mobile or web app, allowing members to seek care when and where it’s most convenient to them. One Medical is designed to better serve the needs of its patients and providers, including through thoughtfully designed and welcoming offices across the U.S., appointments that start on time, more appointment time with providers, and on-site labs. One Medical provides a comprehensive and human-centered primary care experience, including preventive and everyday health visits, chronic care management, pediatric and mental health services in a growing number of locations, and more. Members enjoy access to 24/7/365 virtual care services through the One Medical app, which allows them to continue their care from the comfort of home or on the go, whether it’s for acute needs at odd-hours, or to simply manage follow-up needs and prescription renewals.

  • Do Amazon Prime members receive One Medical memberships?

    No, One Medical membership is separate from Prime membership. For a limited time, One Medical membership, regardless of Prime membership, is available to new U.S. customers for $144 for the first year (regularly $199/year), the equivalent of $12 per month. Visit here to redeem the One Medical membership promotion and learn more about what’s included.

  • How do Amazon and One Medical protect private health information?

    The Health Insurance Portability and Accountability Act (HIPAA) governs what One Medical, Amazon, and others can do with Protected Health Information and this includes information like medication history, medical conditions, and treatment information. Amazon and One Medical have extensive experience protecting data of all kinds appropriately across a variety of businesses and nothing about this acquisition changes Amazon or One Medical’s commitment to privacy or the strong protections we have for Protected Health Information.

About Amazon
Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. Amazon strives to be Earth’s Most Customer-Centric Company, Earth’s Best Employer, and Earth’s Safest Place to Work. Customer reviews, 1-Click shopping, personalized recommendations, Prime, Fulfillment by Amazon, AWS, Kindle Direct Publishing, Kindle, Career Choice, Fire tablets, Fire TV, Amazon Echo, Alexa, Just Walk Out technology, Amazon Studios, and The Climate Pledge are some of the things pioneered by Amazon. For more information, visit amazon.com/about and follow @AmazonNews.

About One Medical
One Medical is a U.S. national human-centered and technology-powered primary care organization with seamless digital health and inviting in-office care, convenient to where people work, shop, live, and click. One Medical’s vision is to delight millions of members with better health and better care while reducing costs, within a better team environment. One Medical’s mission is to transform health care for all through a human-centered, technology-powered model. Headquartered in San Francisco, 1Life Healthcare, Inc. is the administrative and managerial services company for the affiliated One Medical physician-owned professional corporations that deliver medical services in-office and virtually. 1Life and the One Medical entities do business under the “One Medical” brand.

Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements. We use words and phrases such as anticipate, believe, expect, intend, look to, set our sights on, mission, future, and similar expressions to identify forward-looking statements. Actual results could differ materially from those contemplated by the forward-looking statements. Factors that could cause actual results to differ materially include the following: Amazon may be unable to achieve the anticipated benefits of the transaction; Amazon may be unsuccessful in integrating One Medical’s business into its operations; operating costs, customer loss, and business disruption (including, without limitation, difficulties in maintaining relationships with employees, customers, partners, and commercial counterparties) may be greater than expected; Amazon may assume unexpected risks and liabilities; initiatives with One Medical may distract Amazon’s management from other important matters; regulatory impediments may arise, either with respect to the acquisition itself or Amazon’s operation of One Medical’s business; and the other factors discussed in “Risk Factors” in Amazon’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022 and in Amazon’s other filings with the SEC, which are available at http://www.sec.gov. Amazon assumes no obligation to update the information in this press release, except as otherwise required by law. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof.

Contacts
Amazon.com, Inc.
Media Hotline
Amazon-pr@amazon.com
www.amazon.com/pr

Health Tech to Look Out for in 2023

Health Tech to Look Out for in 2023

It is been a bizarre couple of decades for the healthcare engineering sector. In 2020, COVID-19 offered the force the business essential to at last integrate telemedicine into health care shipping in a meaningful way. The pandemic-driven implementation of telehealth also arrived at a time when digital overall health proliferated, as extra health care sector gamers understood that smartphones, watches and other gadgets could be employed as respectable professional medical resources and not just for information and facts supply or as self-affirming trackers for the apprehensive nicely.

Very last year the electronic well being marketplace labored tricky to set some daylight between alone and the “wellness” sector, pushing payers to commence embracing more recent technological instruments and making an attempt to elevate the evidentiary expectations for emerging solutions.

It was not, even so, the yr CMS commenced having to pay for prescription digital therapeutics. The laws that would create Medicare payment for such therapeutics remains in a holding sample, whilst the Electronic Therapeutics Alliance, an industry trade group, is optimistic that it will go ahead in the coming year. That legislation’s destiny is a person of several thoughts struggling with the healthcare technologies sector this yr. Lots of tech corporations are shedding employees, and inflation and the ongoing outcomes of the pandemic have stretched budgets and knocked a lot of individuals off their therapy designs.

Managed Health care Govt® spoke to leaders in health care know-how about what they hope to see in 2023. Themes bundled tougher specifications for digital resources, larger anticipations from sufferers concerning health care technological innovation, and a need for suppliers to be additional innovative as they look for to leverage new instruments to aid offset difficult financial situations.

‘Removing the noise’

Sam Glassenberg, M.S., founder and CEO of Amount Ex, a Chicago-dependent organization that takes advantage of movie match technologies to offer you coaching and simulations for healthcare professionals, says he thinks the new calendar year will be 1 in which the broad globe of digital health and fitness technological innovation is sorted into those that deliver true price and individuals that do not.

“Following all the metaverse hoopla in 2022, the 2023 overall economy is heading to serve as a fantastic filter, eradicating the noise while driving better adoption of the purposes that deliver real, enduring worth,” he tells Managed Health care Executive®.

Glassenberg believes his business is perfectly positioned to profit from these types of a shift, because it facilitates collaborative, distant clinical and surgical coaching in a format that lessens the time and travel burdens traditionally associated with continuing professional medical instruction. “The macroeconomic condition is constraining budgets for each healthcare machine and pharmaceutical companies, as properly as hospitals,” he states.

Resurgence of preventive treatment

The increasing emphasis on benefit in health care will translate into a resurgence in preventive care, predicts Alecia Pritchett, the chief progress officer at Ixlayer, a San Francisco company that facilitates distant health care tests. She states the pandemic took a main toll on preventive care, as quite a few folks stopped generating nonurgent healthcare visits or were preoccupied by a lot more fast concerns, this sort of as a bout of COVID-19 or unemployment.

Pritchett points to a 2020 study that showed far more than a person-third of sufferers with persistent circumstances said their wellness was “noticeably worse” than at the get started of the pandemic. Pritchett states the drop in overall health is connected to several persons missing significant visits and checkups. When that comes about, finally anything must give, she suggests.

“As healthcare devices and ideas are remaining pushed to the limits and are faced with the economical and health and fitness repercussions of these worsening and long-term conditions, they will want to request preventive approaches to get in advance of condition development,” Pritchett provides.

Ixlayer hopes to capitalize on the preventive hiatus by producing it easier for professional medical screening to be done at household, and at a reduce charge. “At-home screening and diagnostic screening lets people to complete the exam where by and when it is convenient and cozy for them,” Pritchett suggests.

Far more direct-to-customer health analytics

Victor Brown, MBA, the CEO and founder of the health and fitness and wellness application maker Xcellent Lifestyle, states he thinks 2023 will be a yr in which health care insights generated by the copious amounts of own well being information grow to be extra extensively obtainable in a direct-to-consumer format. “Specifically,” says Brown, “I am anticipating the industry for wellness analytics, health and fitness chance management, health and fitness education and customized health remedies that are sold instantly to the client to see an elevated progress charge.”

As Brown sees it, the pandemic brought about a new ease and comfort level and increased customer need for cellular wellness technologies. The economics of healthcare are also forcing alter, in his feeling. “The hole concerning how we obtain other services vs . how we obtain health care is creating growing discontent with traditional significant-value, small-worth companies,” he states.

Brown thinks a new regulatory framework is on its way that will make it simpler and faster for new technologies to get into the hands of people — and that, in his look at, is only the starting: “I feel it will usher in a new period of expanding longevity in human existence and an improved high-quality of existence given the abilities of preserving human wellness with know-how.”

Patient well being coverage literacy

Ryan Bullock, main running officer at the medical device maker Aeroflow Healthcare, which is headquartered in Asheville, North Carolina, states affected person empowerment also usually means enabling sufferers to be a lot more informed when selecting wellness plans.

In a landscape in which a new wave of electronic wellbeing units is joining the secure of extra established long lasting medical products, he states people purchasing for insurance policy will want to know which program gives the finest coverage for the devices and equipment upon which they count.

“They should really ascertain regardless of whether their equipment is included less than each individual potential health and fitness system and how the associated fees are managed,” he claims. “Just because a wellbeing system involves coverage for healthcare products doesn’t indicate the company will completely protect the expenses.”

1 way sufferers could get solutions is to call their health care service provider and request them to reveal which expenses would be handed on to consumers, even though companies generally are not acquainted with the details of wellbeing coverage. On the other hand, Bullock also mentioned patients can — and really should — be expecting their insurers to deliver clear info on their websites or applications.

“Many health and fitness options also have on the internet equipment in which you can study the companies by the strategy varieties,” he claims. “Carefully appraise their applications online and verify for relieve of use. It can be a good indicator of the price procedure of the wellbeing approach.”

Fantastic-tuned internet marketing

But it is not only overall health programs that have to have to step up their online advertising and marketing video games. Rob Dreussi, main details officer at HCTec, a healthcare IT agency in Brentwood, Tennessee, claims well being techniques need to boost their “digital entrance doors.” He expects wellbeing devices to enhance their use of digital internet marketing procedures and applications to strengthen affected individual adherence.

“We anticipate accelerated adoption of campaign-dependent outreach to buyers and sufferers,” he suggests. “These campaigns span email reminders for preventive screening and the use of internet-dependent well being danger assessments to identify buyers that could advantage from interventions like a knee substitute, for case in point.”

Dreussi reported several wellness programs have traditionally relied on purchaser romantic relationship management (CRM) program supplied by their digital wellbeing information provider. He expects that more well being units will start out to take into account CRM programs from outside the house the health care industry, these as Salesforce, though he additional that these types of programs would will need to adopt privateness-protection procedures thanks to the privateness requirements of the health care marketplace.

This posting initially appeared in Managed Health care Government.